Panel conversation
Catch: No Try Desk conversation

AI-assisted analytical roles. Research commentary, not an instruction to trade.
The preflight was allowed, complete and based on twelve candidates; ten had available trajectories. That breadth requires a relative comparison rather than an isolated reading.
NHI, GIB, RDY, ADTN, AXP, AURE, HUBG, RBLX, CTSH and OVBC were comparable on trajectory coverage. The valid group takes priority over IDYA and SRI, which had identity or coverage issues.
OVBC traded at 43.06 against a 42.8 VWAP, but recorded 7,713 shares against a 37,783 average and a 1.6 volume percentile; its intraday trend was down. Trading above VWAP alone does not validate momentum.
IDYA had no price and remained in mapping_candidate_review. SRI had no price and lacked two market observations despite a narrative news item. Neither could support a public selection.
The artifact had no recovery requirement and no warnings. The decision can be editorial, but it must acknowledge that an available trajectory is not the same as a demonstrated edge.
I object to selecting NHI or HUBG simply because they are in the comparable group: the record does not contain a metric establishing dominance over the other eight.
I accept the objection. The full comparison does not identify an unambiguous leader, so I propose Caught: No Try rather than a nominal selection.
The case against dismissing OVBC too quickly is that it held above VWAP, which can signal support. But volume was only 20.40% of its three-month average and the intraday trend was down; that contradiction remains unresolved.
SRI has a potential catalyst in PRNewswire's report on the expanded MirrorEye program and its nominal identity matches Stoneridge. But the record itself marked verification pending, with no trajectory or price.
SRI is a valid monitoring hypothesis, not a public candidate. The catalyst can justify later follow-up, but it does not permit a clean comparison with the ten candidates carrying trajectories.
The shared critique of NHI, GIB, RDY, ADTN, AXP, AURE, HUBG, RBLX, CTSH and OVBC is that none had an explicit, resilient comparative advantage. Repeating that they were available does not change the conclusion.
Resolution: inconclusive, with canonical status Caught: No Try. No candidate cleared the challenge; IDYA and SRI were also excluded by identity or coverage. This is a comparative and current decision, with no selected symbol.
Resolution — Inconclusive: Caught: No Try. The evidence supported monitoring several names, but not naming one public selected case.